Seigo Kashii began his career with Astellas Pharma Inc. (formerly Fujisawa Pharmaceutical Co., Ltd.) where he held positions in Sales, Legal Affairs, Corporate Planning & Strategy, before becoming Corporate Executive Vice President of Legal Affairs and President and CEO of Astellas US, Inc. covering North and South America.
After returning to Japan from the US in 2011, he became the Corporate Auditor and Chair of the Audit & Supervisory Board of Astellas. Retiring from Astellas in 2014, Mr. Kashii joined Novartis Pharma K.K. as Corporate Officer and Head of the Integrity & Compliance Division and Japan Country Head for Novartis Group. In that role he was in charge of reconstructing and reinforcing the integrity and compliance structure of Novartis in Japan.
In 2016, Mr. Kashii became an outside director of Healios K.K., a leading company in Japan in the research and development, manufacture, and sale of cell therapy and regenerative medicine products. He serves as Chairs of the Audit Committee and the Compensation Committee and a member of the Nominating Committee at Healios.
In 2021, he became a Senior Advisor to Lakewood Advisors, LLC, a boutique New York City financial advisory firm, and a member of the Advisory Board of Directors of Avara Pharmaceutical Services, Ltd.
Mr. Kashii received a Bachelor of Pharmacy degree from Kyoto College of Pharmacy and became a licensed registered pharmacist in Japan in 1978. In 1992, he earned a law degree from the University of Kobe.
This person is not in the org chart
This person is not in any teams